DATE
10-13 September 2020
LOCATION
Chiang Mai International Exhibition and Convention Centre
TICKETS
Limited Onsite Ticket
Unlimited Online Ticket
SPEAKERS
45 Speakers

Ticket Type
Online / Onsite

ON-LINE meeting

4,500฿
Book Now
  • 1. ACCESS SESSION ONLINE REAL TIME
  • 2. Q and A BOOK DELIVER TO YOUR DOOR
  • 3. ACCESS TO CONGRESS SESSION AFTER CONFERENCE 4 WEEKS

ON-SITE meeting

4,500฿
  • 1. ACCESS ONSITE SESSION ALL AREA + EXHIBITION
  • 2. Q and A BOOK
  • 3. CONGRESS BAG
  • 4. BADGE
  • 5. BREAKFAST / LUNCH / DINNER
  • 6. COFFEE BREAK
  • 7. ACCESS TO CONGRESS SESSION AFTER CONFERENCE 4 WEEKS

Event Schedule

CMCC LINK
FACE & PHONE
10-13 September 2020
Chiang Mai International Exhibition and Convention Centre

10 September 2020

  • Revolution in CV Prevention
    10.30-12.00

    Mendelian Randomization : A Guide for Clinician
    Big-Data and Real-World Study
    Inflammation and CVD :  A New Treatment Target ?

  • Transfer time
    12.00-12.15
  • LUNCH SYMPOSIUM
    12.15-13.15
  • Transfer time
    13.15-13.30
  • Revolution in Hypertension
    13.30-14.30

    Thai In-Hospital Hypertension Screening Study
    Bedtime Medication
    Personal Blood Pressure Monitoring Device

  • Revolution in non-traditional CV risk factors

    Effects of PM2.5 on cardiovascular system
    Effects of COVID-19 on cardiovascular system
    Effects of psychosocial stress on cardiovascular system

  • COFFEE BREAK
    14.30-15.00
  • Concern issues in CV risk management
    15.00-16.00

    Metformin, revisited benefit and risk?
    Smoking:  e-cigarette, dawn or down?
    Possible harm of dietary supplements

  • Check-up program: More tests, less benefits?

    Biomarkers
    Non-coronary vascular study
    Coronary imaging study

  • DINNER SYMPOSIUM
    16.30-18.00

11 September 2020

  • BREAKFAST SYMPOSIUM
    07.15-08.15
  • Opening ceremony
    08.30-09.00
  • Revolution in acute coronary syndrome management
    09.00-10.30

    Thai ACS registry: Past Present and Future
    Thai PCI registry: Quality of care and room for improvement
    Artificial Intelligence and technology in ACS management

  • COFFEE BREAK
    10.30-11.00
  • Revolution in chronic coronary syndrome management
    11.00-12.00

    From ORBITA to ISCHEMIA, any place for revascularization?
    How coronary CTA leverage patient care in CCS?
    Innovative interventional strategies

  • Challenges in acute coronary syndrome

    Uncertain diagnosis: Role of imaging test
    Arrhythmia management in ACS
    Cardiogenic shock in ACS

  • Transfer time
    12.00-12.15
  • LUNCH SYMPOSIUM
    12.15-13.15
  • Transfer time
    13.15-13.30
  • Atherosclerotic disease: Beyond conventional therapy
    13.30-14.30

    Polyvascular disease: Don’t miss it!
    Genotype Guided Strategy for P2Y12i use
    MINOCA and INOCA (non-obstructive CAD)

  • Heart and Brain: common comorbidities

    Revolution in acute ischemic stroke therapy
    ESUS and AF screening, can technology help?
    When to perform PFO closure in stroke patients?

  • COFFEE BREAK
    14.30-15.00
  • Revolution in Revascularization
    15.00-16.00

    Revascularization in LV systolic dysfunction
    Revascularization in left main
    Revascularization in diabetes

  • Difficult issues in coronary artery disease

    Asymptomatic coronary artery stenosis from CTA
    ACS management in patients taking OAC
    Dealing with high bleeding risk patients

  • DINNER SYMPOSIUM
    16.30-18.00

12 September 2020

  • BREAKFAST SYMPOSIUM
    07.15-08.15
  • Revolution in AF Management
    08.30-09.30

    How to prevent AF without antiarrhythmic drugs
    How to use antiarrhythmic drugs properly
    Any promising data on interventional procedures?

  • Heart failure with co-morbidities: Double jeopardy!

    Heart failure and Iron deficiency
    Heart failure and COPD
    Heart failure and advanced renal disease

  • COFFEE BREAK
    09.30-10.00
  • Acute heart failure: Therapy during hospitalization
    10.00-11.00

    IV drugs, how to choose?
    Oral drugs, start/switch/stop?
    Decision pathway in acute heart failure therapy

  • Stroke prevention in uncertain area

    Post-op AF/AF during critical illness
    AF in ESRD
    LAA occlusion, when and how?

  • Revolution in chronic heart failure therapy:
    11.00-12.00

    Promising drugs in HFrEF
    Amyloid heart
    Hypertrophic cardiomyopathy

  • Cardiovascular diseases in pregnancy

    Structural heart, can pregnancy go on?
    Common consultation (Arrhythmias/HT)
    Peripartum cardiomyopathy

  • Transfer time
    12.00-12.15
  • LUNCH SYMPOSIUM
    12.15-13.15
  • Transfer time
    13.15-13.30
  • Difficult issues in cardiac consultation
    13.30-14.30

    Hypertensive emergency
    Pulmonary hypertension: appropriate investigations
    Chemotherapy-related cardiomyopathy: what should you advise?

  • Do and Don’t in VHD Management 2020
  • COFFEE BREAK
    14.30-15.00
  • Challenges in adult congenital heart
    15.00-16.00

    Case-based approach

  • Inter Institution Valve Challenge

    How would you do it?
    How I did it!

  • DINNER SYMPOSIUM
    16.30-18.00

13 September 2020

  • BREAKFAST SYMPOSIUM
    07.15-08.15
  • The Best Clinical Trials of 2019
    08.30-9.30

    Prevention
    Arrhythmias
    Heart failure
    CAD

  • COFFEE BREAK
    09.30-10.00
  • Complex issue in arrhythmias
    10.00-11.00

    Approach to premature beat
    Benign syncope vs. malignant syncope
    Patients with cardiac implantable electronic devices

  • Highlights From ESC
    11.00-12.00

    Guidelines 2020
    NSTEACS
    Adult congenital heart disease
    Sports cardiology

  • LUNCH SYMPOSIUM
    12.00-13.00

Venue